RBC Capital Maintains Outperform on Privia Health Gr, Raises Price Target to $32
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsPrice Target
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
RBC Capital analyst Ryan Halsted maintains Privia Health Gr (NASDAQ:PRVA) with a Outperform and raises the price target from $31 to $32.
RBC Capital analyst Ryan Halsted maintains Privia Health Gr (NASDAQ:PRVA) with a Outperform and raises the price target from $31 to $32.
